FDA Grants Orphan Drug Designation to PTX-252 for AML
The FDA has granted an orphan drug designation to PTX-252 for the treatment of patients with acute myeloid leukemia.
Source: onclive.com
Stay updated with breaking news from Ptx 252 . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has granted an orphan drug designation to PTX-252 for the treatment of patients with acute myeloid leukemia.